These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 32546449)

  • 1. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic.
    Merks P; Jakubowska M; Drelich E; Świeczkowski D; Bogusz J; Bilmin K; Sola KF; May A; Majchrowska A; Koziol M; Pawlikowski J; Jaguszewski M; Vaillancourt R
    Res Social Adm Pharm; 2021 Jan; 17(1):1807-1812. PubMed ID: 32546449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 related regulatory change for pharmacists - The case for its retention post the pandemic.
    Lynch M; O'Leary AC
    Res Social Adm Pharm; 2021 Jan; 17(1):1913-1919. PubMed ID: 32893134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic.
    Ghibu S; Juncan AM; Rus LL; Frum A; Dobrea CM; Chiş AA; Gligor FG; Morgovan C
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of pharmacist during the COVID-19 pandemic: A scoping review.
    Visacri MB; Figueiredo IV; Lima TM
    Res Social Adm Pharm; 2021 Jan; 17(1):1799-1806. PubMed ID: 33317760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FIP's response to the COVID-19 pandemic: Global pharmacy rises to the challenge.
    Sousa Pinto G; Hung M; Okoya F; Uzman N
    Res Social Adm Pharm; 2021 Jan; 17(1):1929-1933. PubMed ID: 33317767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward.
    Mallhi TH; Liaqat A; Abid A; Khan YH; Alotaibi NH; Alzarea AI; Tanveer N; Khan TM
    Front Public Health; 2020; 8():561924. PubMed ID: 33364224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies.
    Badreldin HA; Atallah B
    Res Social Adm Pharm; 2021 Jan; 17(1):1946-1949. PubMed ID: 32446652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alaska pharmacists: First responders to the pandemic in the last frontier.
    Paul AK; Bogart T; Schaber AR; Cutchins DC; Robinson RF
    J Am Pharm Assoc (2003); 2021; 61(1):e35-e38. PubMed ID: 33036935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis.
    Cadogan CA; Hughes CM
    Res Social Adm Pharm; 2021 Jan; 17(1):2032-2035. PubMed ID: 32245691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing California Senate Bill 493 in an Outpatient Pharmacy Within an Integrated Health System: Evaluation of the Operational and Clinical Effect of Pharmacist-Ordered Laboratory Tests.
    Delgado HM; Kleinman NP; Makarem AF; Nguyen C
    J Manag Care Spec Pharm; 2020 Mar; 26(3):320-324. PubMed ID: 32105181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
    Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S
    Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists.
    Elnaem MH; Cheema E
    Res Social Adm Pharm; 2021 Jan; 17(1):1938-1941. PubMed ID: 32507575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.
    Paudyal V; Cadogan C; Fialová D; Henman MC; Hazen A; Okuyan B; Lutters M; Stewart D
    Res Social Adm Pharm; 2021 Aug; 17(8):1507-1517. PubMed ID: 33288420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19.
    Erku DA; Belachew SA; Abrha S; Sinnollareddy M; Thomas J; Steadman KJ; Tesfaye WH
    Res Social Adm Pharm; 2021 Jan; 17(1):1954-1963. PubMed ID: 32387230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community Pharmacists: On the frontline of health service against COVID-19 in LMICs.
    Hedima EW; Adeyemi MS; Ikunaiye NY
    Res Social Adm Pharm; 2021 Jan; 17(1):1964-1966. PubMed ID: 32317154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of COVID-19 on pharmacy transitions of care services.
    Herzik KA; Bethishou L
    Res Social Adm Pharm; 2021 Jan; 17(1):1908-1912. PubMed ID: 33162381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic preparedness of community pharmacies for COVID-19.
    Bahlol M; Dewey RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1888-1896. PubMed ID: 32417070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19).
    Surapat B; Sungkanuparph S; Kirdlarp S; Lekpittaya N; Chunnguleum K
    J Clin Pharm Ther; 2021 Feb; 46(1):236-239. PubMed ID: 33085800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded roles of community pharmacists in COVID-19: A scoping literature review.
    Pantasri T
    J Am Pharm Assoc (2003); 2022; 62(3):649-657. PubMed ID: 35120863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
    Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.